Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes patients: a propensity score-matched study
Event: ESC Congress 2022
Topic: Antidiabetic Pharmacotherapy
Session: SGLT2 inhibitors in clinical practice
